Did You Know?

Editor’s Picks

Latest News

Aligos Therapeutics Begins Dosing with Capsid Assembly Modulator Drug Candidate, ALG-000184, in First Cohort of Chronic Hepatitis B Patients in a Phase 1 Proof-of-Concept Study

Aligos now evaluating two of its four Chronic Hepatitis B (CHB) portfolio drug candidates in patientsSOUTH SAN FRANCISCO, Calif., April...

Inozyme Pharma Presents Data from Burden of Illness Study in Patients with ENPP1 Deficiency and ABCC6 Deficiency at the 2021 Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics

error: Content is protected !!